Aims-To investigate the serological cross reaction between legionella and campylobacter using the rapid microagglutination test (RMAT). Methods-Serum samples from 49 patients with campylobacter infection were tested for legionelia antibodies using the indirect fluorescent antibody test (IFAT) and the RMAT. Serum samples that had positive RMAT titres were retested in the presence of a campylobacter immunosorbent. The specificity of the inumunosorbent was evaluated with serum from patients with genuine legionella infection (legionella culture or antigen positive, or both This serological cross reaction can be inhibited by using campylobacter blocking fluid (CBF), prepared from campylobacter Penner reference strain 11, as an immunosorbent in the IFAT. Over 90% of false positive reactions are inhibited using this method, but titres from patients with genuine legionella infection are unaffected.3 A significant number of unexpected false positive results were revealed when this immunosorbent was incorporated into routine diagnostic serology tests.4
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The campylobacter immunosorbent was suitable for distinguishing between genuine and cross reacting serum samples in the RMAT. There was no significant reduction in RMAT titres in any of serum samples from the 48 patients with genuine legionella infection, whereas RMAT titres from 26 of 27 patients with campylobacter infection were significantly reduced (table 3) . No alteration in the RMAT assay performance was seen when the immunosorbent was used with genuine legionella serum samples.
Absence of button formation in the RMAT occurred when some of the campylobacter positive serum samples were diluted in the immunosorbent. This could be because of large complexes of campylobacter antigenantibody-legionella antigen, preventing the formation of a tight button of legionella antigen on centrifugation. Absence of button formation in CBF, but not PBS, could identify cross reacting serum samples as this pattern was not seen with genuine legionella serum samples.
Serum from a patient infected with campylobacter had a high RMAT titre which was not reduced by absorption. The failure of Penner 11 CBF to absorb this cross reaction in the IFAT has been reported before.' Further work has shown that the IFAT and RMAT titres can be reduced in a CBF prepared from Campylobacter lari NCTC 1 1352. Further evaluation of this alternative CBF is planned.
In conclusion, laboratories using the legionella RMAT need to be aware of this important cross reaction. Incorporation of a campylobacter immunosorbent is technically simple and easily distinguishes genuine from cross reacting serum samples.
